Name: analysis of lymph node volume by ultra-high-frequency ultrasound imaging in the braf/pten genetically engineered mouse model of melanoma
Uploaded: 2021-09-08T14:00:00.000+00:00
Duration: 8 min 18 s
Description: Watch this Scientific Journal Video about Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma at JoVE.com

The authors would like to thank S. Burchielli (FTGM, Pisa) for her assistance with animal procedures. This work was supported by ISPRO-Istituto per lo Studio la Prevenzione e la Rete Oncologica institutional funding to LP; MFAG #17095 awarded by AIRC-Associazione Italiana Ricerca sul Cancro to&#160;LP.

All methods described here have been approved by the Italian Ministry of Health (animal protocols #754/2015-PR and #684/2018-PR).
1. Melanoma induction
NOTE: Six-week-old Tyr::CreER+,BrafCA/+,Ptenlox/lox&#160;mice [B6.Cg-Braftm1Mmcm Ptentm1Hwu Tg(Tyr-cre/ERT2)13Bos/BosJ (Braf/Pten)] were used in this study (see the Table of Materials).
<ol>
	<li>Treat the mice with 4-hydroxytamoxifen (4-HT) by applying 3 &#181;L of 5 mM 4-HT on ~1 cm2 of shaved skin of the upper back, as described previously11,16,17, for 3 days in a row. 
	NOTE: This will activate the Cre enzyme and cause a switch from wt Braf to BrafV600E and the loss of Pten. These two hits are enough to induce melanoma formation.</li>
	<li>Observe that&#160;primary tumors develop at the site of the skin painting in 2-3 weeks and reach a volume of 50-100 mm3 in 4 weeks. Also, observe metastases to other skin sites, lymph nodes, and lungs at this time point (t0).</li>
	<li>Use calipers to measure the volume of the primary tumor and of subcutaneous metastases, and ultrasound imaging to measure the volume of the inguinal lymph nodes. Repeat these measurements after one week (t1, 5 weeks after skin painting) and after two weeks (t2, 6 weeks after skin painting).</li>
	<li>At the last time point, euthanize the mice by overdosing with gaseous sevorane.</li>
	<li>Analyze the primary tumor and lymph nodes by visual inspection, then excise them for histological studies, as reported in16.</li>
</ol>
2. Imaging procedure
<ol>
	<li>Place the mouse in an induction chamber for gas anesthesia and supply 3% isoflurane in pure oxygen until the animal is fully anesthetized. Verify the depth of anesthesia by lack of response to paw pinch.</li>
	<li>Transfer the animal to a heated board - a constitutive part of the UHFUS imaging station - holding the animal in a supine position. Use a rectal probe lubricated with petroleum jelly to measure the body temperature. Adjust the board temperature to maintain the mouse&#39;s body temperature in the physiological range (36 &#177; 1&#176;C).</li>
	<li>Moisten the mouse&#39;s eyes with vet ointment to prevent dryness during anesthesia. Supply narcotic gas (1.5% isoflurane in pure oxygen) through a mouse&#39;s nose mask. Adjust the percentage of isoflurane to maintain the correct depth of anesthesia.</li>
	<li>Coat the fore and hind paws with conductive paste and tape them to the ECG plate electrodes embedded in the board. Check that the physiological parameters (heart rate, respiration signal, and core body temperature) are correctly acquired and displayed.</li>
	<li>Remove hair from both inguinal areas by applying a depilatory agent and coat them with an acoustic coupling medium.</li>
	<li>Clamp the UHFUS linear probe (40 MHz center frequency) into a specialized 3D motor embedded in the UHFUS imaging station, allowing automated and stepwise movement of the probe.</li>
	<li>Properly orient and adjust the position of the ultrasound probe to obtain short-axis images of the inguinal lymph node (left/right), and place the region of interest in the focal zone.</li>
	<li>Scan the entire volume of the inguinal lymph node as a sequence of 2D B-mode images, as described previously18. Acquire images at multiple levels of the lymph node by linear movement of the transducer with step sizes on a micrometer scale, to generate 3D data in terms of automatically respiration- and cardiac-gated cine loops.</li>
	<li>Set the image recording with the following parameters: scan distance ranging between 2 and 5 mm (depending on lymph node size); step size 44 &#181;m, with an outcome of 46-114 scan steps/lymph node slices and an acquisition time of 1-3 min per animal. Digitally store the acquired images in raw format (DICOM) for further offline analyses.</li>
	<li>At the end of the imaging session, discontinue the gas anesthesia and allow the animal to recover on the heating board in sternal recumbency. Take care of the animal until it has regained sufficient consciousness to maintain the prone position.</li>
</ol>
3. Post-processing of ultrasound images
<ol>
	<li>Open the dataset of DICOM 3D images of the left/right inguinal lymph node in the software platform for ultrasound image post-processing.</li>
	<li>Segmentation:
	<ol>
		<li>Select Multi-slice Method to visualize both the current frames and thumbnails of all frames corresponding to each image captured during the 3D acquisition.</li>
		<li>Select the thumbnail of the first frame to load it into the contouring view. In the contouring view, left-click on the mouse to drop points along the border of the lymph node. Once the desired number of points has been set (range 10-15), right-click to complete the contour.</li>
		<li>After the first contour is completed, use the thumbnail view to select the next image for contouring. If required, skip over several images (average of 3 frames) between contours to reduce the number of manual traces needed for each 3D volume. 
		NOTE: The software platform for ultrasound image post-processing will automatically generate contours between manual traces, thereby reducing the time of analysis.</li>
		<li>Repeat this process until the entire volume has been outlined. Once complete, click on Finish.</li>
	</ol>
	</li>
	<li>Generation of the 3D wireframe and volume measurement:
	<ol>
		<li>While in the 3D mode window workspace, click on the Volume measurement icon beneath the image display area to activate the surface view. 
		NOTE: The surface view creates a compilation view that maps the user-generated volume to the acquired image. The surface view can be rotated into any desired position.</li>
		<li>Take note of the volume measurement listed in the lower left-hand corner of the cube view. 
		NOTE: Segmentation and 3D volume generation can also be obtained using custom-developed software and/or freely available/commercial software for general image processing. Starting from manual segmentation, the software should provide a mathematical and/or pixel-level description of the lymph node contours. These contours would be combined in a 3D space to render the external surface of lymph nodes. All steps described in the imaging procedure and the post-processing of ultrasound images are summarized in Figure 2.</li>
	</ol>
	</li>
</ol>

<ol>
	<li>Schvartsman, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Management+of+metastatic+cutaneous+melanoma:+updates+in+clinical+practice.">Management of metastatic cutaneous melanoma: updates in clinical practice.</a> Therapeutic Advances in Medical Oncology. 11, 1758835919851663 (2019).</li><li>Blum, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ultrasound+examination+of+regional+lymph+nodes+significantly+improves+early+detection+of+locoregional+metastases+during+the+follow-up+of+patients+with+cutaneous+melanoma+-+Results+of+a+prospective+study+of+1288+patients.">Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma - Results of a prospective study of 1288 patients.</a> Cancer. 88 (11), 2534-2539 (2000).</li><li>Olmedo, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Use+of+lymph+node+ultrasound+prior+to+sentinel+lymph+node+biopsy+in+384+patients+with+melanoma:+a+cost-effectiveness+analysis.">Use of lymph node ultrasound prior to sentinel lymph node biopsy in 384 patients with melanoma: a cost-effectiveness analysis.</a> Actas Dermo-Sifiliograficas. 108 (10), 931-938 (2017).</li><li>Voit, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Ultrasound+morphology+criteria+predict+metastatic+disease+of+the+sentinel+nodes+in+patients+with+melanoma.">Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma.</a> Journal of Clinical Oncology. 28 (5), 847-852 (2010).</li><li>Hayes, A. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Prospective+cohort+study+of+ultrasound+surveillance+of+regional+lymph+nodes+in+patients+with+intermediate-risk+cutaneous+melanoma.">Prospective cohort study of ultrasound surveillance of regional lymph nodes in patients with intermediate-risk cutaneous melanoma.</a> British Journal of Surgery. 106 (6), 729-734 (2019).</li><li>Ipenburg, N. A., Thompson, J. F., Uren, R. F., Chung, D., Nieweg, O. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Focused+ultrasound+surveillance+of+lymph+nodes+following+lymphoscintigraphy+without+sentinel+node+biopsy:+a+useful+and+safe+strategy+in+elderly+or+frail+melanoma+patients.">Focused ultrasound surveillance of lymph nodes following lymphoscintigraphy without sentinel node biopsy: a useful and safe strategy in elderly or frail melanoma patients.</a> Annals of Surgical Oncology. 26 (9), 2855-2863 (2019).</li><li>Jayapal, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differentiation+between+benign+and+metastatic+cervical+lymph+nodes+using+ultrasound.">Differentiation between benign and metastatic cervical lymph nodes using ultrasound.</a> Journal of Pharmacy and Bioallied Sciences. 11, 338-346 (2019).</li><li>Dankort, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Braf(V600E)+cooperates+with+Pten+loss+to+induce+metastatic+melanoma.">Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.</a> Nature Genetics. 41 (5), 544-552 (2009).</li><li>Damsky, W. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=&#946;-catenin+signaling+controls+metastasis+in+Braf-activated+Pten-deficient+melanomas.">&#946;-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.</a> Cancer Cell. 20 (6), 741-754 (2011).</li><li>Xie, X., Koh, J. Y., Price, S., White, E., Mehnert, J. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Atg7+overcomes+senescence+and+promotes+growth+of+BrafV600E-driven+melanoma.">Atg7 overcomes senescence and promotes growth of BrafV600E-driven melanoma.</a> Cancer Discovery. 5 (4), 410-423 (2015).</li><li>Kohler, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mouse+cutaneous+melanoma+induced+by+mutant+BRaf+arises+from+expansion+and+dedifferentiation+of+mature+pigmented+melanocytes.">Mouse cutaneous melanoma induced by mutant BRaf arises from expansion and dedifferentiation of mature pigmented melanocytes.</a> Cell Stem Cell. 21 (5), 679-693 (2017).</li><li>Yuan, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Phenformin+enhances+the+therapeutic+benefit+of+BRAF(V600E)+inhibition+in+melanoma.">Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.</a> Proceedings of the National Academy of Sciences of the United States of America. 110 (45), 18226-18231 (2013).</li><li>Marsh Durban, V., Deuker, M. M., Bosenberg, M. W., Phillips, W., McMahon, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Differential+AKT+dependency+displayed+by+mouse+models+of+BRAFV600E-initiated+melanoma.">Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.</a> Journal of Clinical Investigation. 123 (12), 5104-5118 (2013).</li><li>Hooijkaas, A. I., Gadiot, J., vander Valk, M., Mooi, W. J., Blank, C. U. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Targeting+BRAFV600E+in+an+inducible+murine+model+of+melanoma.">Targeting BRAFV600E in an inducible murine model of melanoma.</a> American Journal of Pathology. 181 (3), 785-794 (2012).</li><li>Steinberg, S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=BRAF+inhibition+alleviates+immune+suppression+in+murine+autochthonous+melanoma.">BRAF inhibition alleviates immune suppression in murine autochthonous melanoma.</a> Cancer Immunology Research. 2 (11), 1044-1050 (2014).</li><li>Vitiello, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Antitumoral+effects+of+attenuated+Listeria+monocytogenes+in+a+genetically+engineered+mouse+model+of+melanoma.">Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma.</a> Oncogene. 38 (19), 3756-3762 (2019).</li><li>Moon, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Melanocyte+stem+cell+activation+and+translocation+initiate+cutaneous+melanoma+in+response+to+UV+exposure.">Melanocyte stem cell activation and translocation initiate cutaneous melanoma in response to UV exposure.</a> Cell Stem Cell. 21 (5), 665-678 (2017).</li><li>Zhao, L., Zhan, Y. T., Rutkowski, J. L., Feuerstein, G. Z., Wang, X. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Correlation+between+2-and+3-dimensional+assessment+of+tumor+volume+and+vascular+density+by+ultrasonography+in+a+transgenic+mouse+model+of+mammary+carcinoma.">Correlation between 2-and 3-dimensional assessment of tumor volume and vascular density by ultrasonography in a transgenic mouse model of mammary carcinoma.</a> Journal of Ultrasound in Medicine. 29 (4), 587-595 (2010).</li></ol>

The authors have nothing to disclose.

The data obtained in this study attest the ability of ultrasound imaging to monitor the metastatic involvement of inguinal lymph nodes of the Braf/Pten mouse model of metastatic melanoma. As shown previously16, this technique is especially useful to assess the efficacy of drug treatment. This is because it allows the monitoring of the change in lymph node volume in the same animal over time, by comparing the measurements collected at t1 and&#160;t2 with those colle...

Melanoma is an aggressive form of skin cancer that often spreads to other skin sites (subcutaneous metastases), as well as to lymph nodes, lungs, liver, brain, and bones1. In the last decade, new drugs have been introduced into clinical practice and have contributed to improving the life expectancy of metastatic melanoma patients. However, limitations remain, including variable time to and degree of response, severe side effects, and the insurgence of acquired resistance1. Therefore, it is crucial to detect metastatic spreading at its early stages, i.e., when it gets to the local lymph nodes.
A biopsy of the local lymph nodes (sentinel lymph nodes) is usually performed to check for the presence of melanoma cells. However, ultrasound imaging is taking hold as a non-invasive method of detecting metastatic involvement, as it outperforms clinical evaluation and can help avoid an unnecessary biopsy2,3,4. Furthermore, ultrasound imaging seems appropriate for lymph node surveillance, especially in the case of advanced age and/or comorbidities5,6. The features that are detected by ultrasound analysis and allow the differentiation between normal and metastatic lymph nodes comprise increased size (volume), change of shape from oval to round, irregular margin, altered echogenic pattern, and altered (increased) vascularization7.
Tyr::CreER+,BrafCA/+,Ptenlox/lox genetically engineered mice (Braf/Pten mice) have recently been made available to the scientific community as a tissue-specific and inducible model for metastatic melanoma8. In this animal model, primary tumors develop very quickly: they become visible within 2-3 weeks after the induction of the switch from wild-type (wt) Braf to BrafV600E and of the loss of Pten, while they reach a volume of 50-100 mm3 within 4 weeks. In the following 2 weeks, the growth of the primary tumor is accompanied by a progressive increase in metastatic burden in other skin sites, lymph nodes, and lungs.
Braf/Pten mice have been extensively used for multiple purposes including the dissection of signaling pathways involved in melanomagenesis9,10, the identification of melanoma cells of origin11,12,13, and the testing of new therapeutic options in terms of both targeted therapy and immunotherapy8,14,15,16. Specifically, we used Braf/Pten mice to demonstrate that attenuated Listeria monocytogenes (Lmat) works as an anti-melanoma vaccine. When systemically administered in the therapeutic setting, Lmat is not associated with overall toxicity as it selectively accumulates at tumor sites. Furthermore, it causes a remarkable decrease in primary melanoma mass and a reduction in metastatic burden in the lymph nodes and lungs. At the molecular level, Lmat causes apoptotic killing of melanoma cells, which is due, at least in part, to non-cell-autonomous activities (recruitment on-site of CD4+ and CD8+ T lymphocytes)16.
When Braf/Pten mice are used for melanoma modeling, the growth of primary tumors and subcutaneous metastases can be monitored by caliper measurements. However, the involvement of lymph nodes and lungs needs to be investigated using an alternative technique, possibly a non-invasive one that allows researchers to follow the same animal over time. This paper describes the use of ultrasound imaging (Figure 1), coupled with a subsequent 3D volumetric analysis of the obtained data, for the longitudinal monitoring of the increase in size (volume) of inguinal lymph nodes.

<table><tbody><tr><td>4-hydroxytamoxifen</td><td>Merck</td><td>H6278</td><td>drug used for tumor induction</td></tr><tr><td>B6.Cg-Braftm1Mmcm Ptentm1Hwu Tg(Tyr-cre/ERT2)13Bos/BosJ (Braf/Pten) mice</td><td>The Jackson Laboratory</td><td>013590</td><td></td></tr><tr><td>Blu gel</td><td>Sooft Ialia</td><td></td><td>ophthalmic solution gel</td></tr><tr><td>BRAFV600E antibody</td><td>Spring Bioscience Corporation</td><td>E19290</td><td></td></tr><tr><td>IsoFlo (isoflorane)</td><td>Zoetis</td><td></td><td>liquid for gaseous anaesthesia</td></tr><tr><td>MLANA antibody</td><td>Thermo Fisher Scientific</td><td>M2-7C10</td><td></td></tr><tr><td>Sigma gel</td><td>Parker</td><td></td><td>electrode gel</td></tr><tr><td>Transonic gel clear</td><td>Telic SAU</td><td></td><td>ultrasound gel</td></tr><tr><td>Veet</td><td>Reckitt Benckiser IT</td><td></td><td>depilatory cream</td></tr><tr><td>Compact Dual Anesthesia System</td><td>Fujifilm, Visualsonics Inc.</td><td></td><td>Isoflurane-based anesthesia system equipped with nose cone and induction chamber</td></tr><tr><td>MX550S</td><td>Fujifilm, Visualsonics Inc.</td><td></td><td>UHFUS linear probe</td></tr><tr><td>Vevo 3100</td><td>Fujifilm, Visualsonics Inc.</td><td></td><td>UHFUS system</td></tr><tr><td>Vevo Imaging Station</td><td>Fujifilm, Visualsonics Inc.</td><td></td><td>UHFUS imaging station and Advancing Physiological Monitoring Unit endowed with heated board</td></tr><tr><td>Vevo Lab</td><td>Fujifilm, Visualsonics Inc.</td><td></td><td>software platform for ultrasound image post-processing</td></tr></tbody></table>

analysis of lymph node volume by ultra-high-frequency ultrasound imaging in the braf/pten genetically engineered mouse model of melanoma

Tyr::CreER+,BrafCA/+,Ptenlox/lox&#160;genetically engineered mice (Braf/Pten mice) are widely used as an in vivo model of metastatic melanoma. Once a primary tumor has been induced by tamoxifen treatment, an increase in metastatic burden is observed within 4-6 weeks after induction. This paper shows how Ultra-High-Frequency UltraSound (UHFUS) imaging can be exploited to monitor the increase in metastatic involvement of the inguinal lymph nodes by measuring the increase in their volume.
The UHFUS system is used to scan anesthetized mice with a UHFUS linear probe (22-55 MHz, axial resolution 40 &#181;m). B-mode images from the inguinal lymph nodes (both left and right sides) are acquired in a short-axis view, positioning the animals in dorsal recumbency. Ultrasound records are acquired using a 44 &#181;m step size on a motorized mechanical arm. Afterward, two-dimensional (2D) B-mode acquisitions are imported into the software platform for ultrasound image post-processing, and inguinal lymph nodes are identified and segmented semi-automatically in the acquired cross-sectional 2D images. Finally, a total reconstruction of the three-dimensional (3D) volume is automatically obtained along with the rendering of the lymph node volume, which is also expressed as an absolute measurement.
This non-invasive in vivo technique is very well tolerated and allows the scheduling of multiple imaging sessions on the same experimental animal over 2 weeks. It is, therefore, ideal to assess the impact of pharmacological treatment on metastatic disease.

After skin painting of Tyr::CreER+,BrafCA/+,Ptenlox/lox&#160;mice with 4-HT, Cre activity is induced, due to which there is a switch at the genomic level from wt Braf to BrafV600E, while Pten is lost (Figure 3A). In 2-3 weeks, mice develop on-site primary tumors with 100% penetrance. After four weeks from 4-HT treatment (t0), primary tumors reach a volume of 50-100 mm3, and their growth can be measured by calipers for an additiona...

Watch this Scientific Journal Video about Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma at JoVE.com

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Melanoma is a very aggressive disease that quickly spreads to other organs. This protocol describes the application of ultra-high-frequency ultrasound imaging, coupled with 3D rendering, to monitor the volume of the inguinal lymph nodes in the Braf/Pten mouse model of metastatic melanoma.

Tyr::CreER+,BrafCA/+,Ptenlox/lox&#160;genetically engineered mice (Braf/Pten mice) are widely used as an in vivo model of metastatic melanoma. Once a ...

analysis-lymph-node-volume-ultra-high-frequency-ultrasound-imaging

Research

JoVE Journal

Cancer Research

2.9K Views.  National Research Council (IFC-CNR). Melanoma is a very aggressive disease that quickly spreads to other organs. This protocol describes the application of ultra-high-frequency ultrasound imaging, coupled with 3D rendering, to monitor the volume of the inguinal lymph nodes in the Braf/Pten mouse model of metastatic melanoma.

Video: Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models

The LSL-KrasG12D/+; LSL-Trp53R172H/+; Pdx-1-Cre (KPC) mouse model represents an established and frequently used transgenic model to evaluate novel therapies in pancreatic cancer. Tumor onset is variable in the KPC model between 8 weeks and several months. Therefore, non-invasive imaging tools are required to screen for tumor onset and monitor for response to treatment. To address this issue, different approaches have emerged over the last years. High resolution ultrasound has major advantages such as non-invasiveness, fast session times and a high image resolution without radiation exposure. However, ultrasound in mice is not trivial and sufficient anatomical knowledge and practical skills are required to successfully perform high resolution ultrasound in preclinical pancreatic cancer models. With the following article, a detailed hands-on guide for abdominal ultrasound in murine models with a particular focus on endogenous pancreatic cancer models is presented. Furthermore, a summary of common mistakes and how to avoid them is provided.

This article describes the utilization of high-resolution ultrasound in genetically engineered pancreatic cancer mice. The primary aim is to provide a detailed instruction for detection and evaluation of endogenous pancreatic tumors.

The LSL-KrasG12D/+; LSL-Trp53R172H/+; Pdx-1-Cre (KPC) mouse model represents an established and frequently used transgenic model to evaluate novel ...

Non-invasive Optical Imaging of the Lymphatic Vasculature of a Mouse

The lymphatic vascular system is an important component of the circulatory system that maintains fluid homeostasis, provides immune surveillance, and mediates fat absorption in the gut. Yet despite its critical function, there is comparatively little understanding of how the lymphatic system adapts to serve these functions in health and disease1. Recently, we have demonstrated the ability to dynamically image lymphatic architecture and lymph "pumping" action in normal human subjects as well as in persons suffering lymphatic dysfunction using trace administration of a near-infrared fluorescent (NIRF) dye and a custom, Gen III-intensified imaging system2-4. NIRF imaging showed dramatic changes in lymphatic architecture and function with human disease. It remains unclear how these changes occur and new animal models are being developed to elucidate their genetic and molecular basis. In this protocol, we present NIRF lymphatic, small animal imaging5,6 using indocyanine green (ICG), a dye that has been used for 50 years in humans7, and a NIRF dye-labeled cyclic albumin binding domain (cABD-IRDye800) peptide that preferentially binds mouse and human albumin8. Approximately 5.5 times brighter than ICG, cABD-IRDye800 has a similar lymphatic clearance profile and can be injected in smaller doses than ICG to achieve sufficient NIRF signals for imaging8. Because both cABD-IRDye800 and ICG bind to albumin in the interstitial space8, they both may depict active protein transport into and within the lymphatics. Intradermal (ID) injections (5-50 &mu;l) of ICG (645 &mu;M) or cABD-IRDye800 (200 &mu;M) in saline are administered to the dorsal aspect of each hind paw and/or the left and right side of the base of the tail of an isoflurane-anesthetized mouse. The resulting dye concentration in the animal is 83-1,250 &mu;g/kg for ICG or 113-1,700 &mu;g/kg for cABD-IRDye800. Immediately following injections, functional lymphatic imaging is conducted for up to 1 hr using a customized, small animal NIRF imaging system. Whole animal spatial resolution can depict fluorescent lymphatic vessels of 100 microns or less, and images of structures up to 3 cm in depth can be acquired9. Images are acquired using V++ software and analyzed using ImageJ or MATLAB software. During analysis, consecutive regions of interest (ROIs) encompassing the entire vessel diameter are drawn along a given lymph vessel. The dimensions for each ROI are kept constant for a given vessel and NIRF intensity is measured for each ROI to quantitatively assess "packets" of lymph moving through vessels.

Recently developed imaging techniques using near-infrared fluorescence (NIRF) may help elucidate the role the lymphatic system plays in cancer metastasis, immune response, wound repair, and other lymphatic-associated diseases.

The lymphatic  vascular system is an important component of the circulatory system that  maintains fluid homeostasis, provides immune surveillance, and ...

Immunology and Infection

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited therapeutic options. When compared to patients with less aggressive breast tumors, the 5-year survival rate of TNBC patients is 77% due to their characteristic drug-resistant phenotype and metastatic burden. Toward this end, murine models have been established aimed at identifying novel therapeutic strategies limiting TNBC tumor growth and metastatic spread. This work describes a practical guide for the TNBC orthotopic model where MDA-MB-231 breast cancer cells suspended in a basement membrane matrix are implanted in the fourth mammary fat pad, which closely mimics the cancer cell behavior in humans. Measurement of tumors by caliper, lung metastasis assessment via in vivo and ex vivo imaging, and molecular detection are discussed. This model provides an excellent platform to study therapeutic efficacy and is especially suitable for the study of the interaction between the primary tumor and distal metastatic sites.

This work presets an advanced protocol to accurately assess tumor loading by detection of green fluorescent protein and bioluminescence signals as well as the integration of quantitative molecular detection technique.

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited therapeutic options. When compared to patients with less ...

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

With ~1.6 million victims per year, lung cancer contributes tremendously to the worldwide burden of cancer. Lung cancer is partly driven by genetic alterations in oncogenes such as the KRAS oncogene, which constitutes ~25% of lung cancer cases. The difficulty in therapeutically targeting KRAS-driven lung cancer partly stems from having poor models that can mimic the progression of the disease in the lab. We describe a method that permits the relative quantification of primary KRAS lung tumors in a Cre-inducible LSL-KRAS G12D mouse model via ultrasound imaging. This method relies on brightness (B)-mode acquisition of the lung parenchyma. Tumors that are initially formed in this model are visualized as B-lines and can be quantified by counting the number of B-lines present in the acquired images. These would represent the relative tumor number formed on the surface of the mouse lung. As the formed tumors develop with time, they are perceived as deep clefts within the lung parenchyma. Since the circumference of the formed tumor is well-defined, calculating the relative tumor volume is achieved by measuring the length and width of the tumor and applying them in the formula used for tumor caliper measurements. Ultrasound imaging is a non-invasive, fast and user-friendly technique that is often used for tumor quantifications in mice. Although artifacts may appear when obtaining ultrasound images, it has been shown that this imaging technique is more advantageous for tumor quantifications in mice compared to other imaging techniques such as computed tomography (CT) imaging and bioluminescence imaging (BLI). Researchers can investigate novel therapeutic targets using this technique by comparing lung tumor initiation and progression between different groups of mice.

This protocol describes the steps taken to induce KRAS lung tumors in mice as well as the quantification of formed tumors by ultrasound imaging. Small tumors are visualized in early timepoints as B-lines. At later timepoints, relative tumor volume measurements are achieved by the measurement tool in the ultrasound software.

With ~1.6 million victims per year, lung cancer contributes tremendously to the worldwide burden of cancer. Lung cancer is partly driven by genetic ...

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Cancer-associated fibroblasts (CAFs) can play an important role in tumor growth by creating a tumor-promoting microenvironment. Models to study the role of CAFs in the tumor microenvironment can be helpful for understanding the functional importance of fibroblasts, fibroblasts from different tissues, and specific genetic factors in fibroblasts. Mouse models are essential for understanding the contributors to tumor growth and progression in an in vivo context. Here, a protocol in which cancer cells are mixed with fibroblasts and introduced into mice to develop tumors is provided. Tumor sizes over time and final tumor weights are determined and compared among groups. The protocol described can provide more insight into the functional role of CAFs in tumor growth and progression.

A protocol to co-inject cancer cells and fibroblasts and monitor tumor growth over time is provided. This protocol can be used to understand the molecular basis for the role of fibroblasts as regulators of tumor growth.

Cancer-associated fibroblasts (CAFs) can play an important role in tumor growth by creating a tumor-promoting microenvironment. Models to study the role ...

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Anaplastic thyroid carcinoma (ATC) is associated with a poor prognosis and short median survival time, but no effective treatment improves the outcomes significantly. Genetically engineered murine models that mimic ATC&#39;s progression may help researchers to study treatments for this disease. Crossing three different genotypes of mice, a TPO-cre/ERT2; BrafCA/wt; Trp53&#916;ex2-10/&#916;ex2-10&#160;transgenic ATC model was developed. The ATC murine model was induced by an intraperitoneal injection of tamoxifen with overexpression of BrafV600E and deletion of Trp53, and the tumors were generated within about 1 month. High-resolution ultrasound was applied to investigate the tumor initiation and progression, and the dynamic growth curve was obtained by measuring the tumor sizes. Compared to magnetic resonance imaging (MRI) and computed tomography scanning, ultrasound has advantages in observing the ATC murine model, such as being noninvasive, portable, in real-time, and without radiation exposure. High-resolution ultrasound is suitable for dynamic and multiple measurements. However, ultrasonographic examination of the thyroid in mice requires relevant anatomical knowledge and experience. This article provides a detailed procedure for utilizing high-resolution ultrasound to scan tumors in the transgenic ATC model. Meanwhile, ultrasonic parameter adjustment, ultrasound scanning skills, anesthesia and recovery of the animals, and other elements that need attention during the process are listed.

The present protocol describes high-frequency ultrasonography for visualizing the entire mouse thyroid gland and monitoring the growth of anaplastic thyroid carcinoma.

Anaplastic thyroid carcinoma (ATC) is associated with a poor prognosis and short median survival time, but no effective treatment improves the outcomes ...

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Uterine cancers can be studied in mice due to the ease of handling and genetic manipulation in these models. However, these studies are often limited to assessing pathology post-mortem in animals euthanized at multiple time points in different cohorts, which increases the number of mice needed for a study. Imaging mice in longitudinal studies can track the progression of disease in individual animals, reducing the number of mice needed. Advances in ultrasound technology have allowed for the detection of micrometer-level changes in tissues. Ultrasound has been used to study follicle maturation in ovaries and xenograft growth but has not been applied to morphological changes in the mouse uterus. This protocol examines the juxtaposition of pathology with in vivo imaging comparisons in an induced endometrial cancer mouse model. The features observed by ultrasound were consistent with the degree of change seen by gross pathology and histology. Ultrasound was found to be highly predictive of the observed pathology, supporting the incorporation of ultrasonography into longitudinal studies of uterine diseases such as cancer in mice.

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

This protocol describes a method for monitoring the progression of morphological changes over time in the uterus in an inducible mouse model of endometrial cancer using ultrasound imaging with correlation to gross and histological changes.

Uterine cancers can be studied in mice due to the ease of handling and genetic manipulation in these models. However, these studies are often limited to ...

High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes

High-frequency ultrasound (HFUS) is widely employed as a non-invasive method for imaging internal anatomic structures in experimental small animal systems. HFUS has the ability to detect structures as small as 30 &#181;m, a property that has been utilized for visualizing superficial lymph nodes in rodents in brightness (B)-mode. Combining power Doppler with B-mode imaging allows for measuring circulatory blood flow within lymph nodes and other organs. While HFUS has been utilized for lymph node imaging in a number of mouse&#160; model systems, a detailed protocol describing HFUS imaging and characterization of the cervical lymph nodes in mice has not been reported. Here, we show that HFUS can be adapted to detect and characterize cervical lymph nodes in mice. Combined B-mode and power Doppler imaging can be used to detect increases in blood flow in immunologically-enlarged cervical nodes. We also describe the use of B-mode imaging to conduct fine needle biopsies of cervical lymph nodes to retrieve lymph tissue for histological&#160; analysis. Finally, software-aided steps are described to calculate changes in lymph node volume and to visualize changes in lymph node morphology following image reconstruction. The ability to visually monitor changes in cervical lymph node biology over time provides a simple and powerful technique for the non-invasive monitoring of cervical lymph node alterations in preclinical mouse models of oral cavity disease.

This protocol describes the application of high-frequency ultrasound (HFUS) for imaging mouse cervical lymph nodes. This technique optimizes visualization and quantification of cervical lymph node morphology, volume and blood flow. Image-guided biopsy of cervical lymph nodes and processing of lymph tissue for histological evaluation is also demonstrated.

High-frequency ultrasound (HFUS) is widely employed as a non-invasive method for imaging internal anatomic structures in experimental small animal ...

Medicine

A Murine Tail Lymphedema Model

Lymphedema is extremity swelling caused by lymphatic dysfunction. The affected limb enlarges because of accumulation of fluid, adipose, and fibrosis. There is no cure for this disease. A mouse tail model that uses a focal full thickness skin excision near the base of the tail, resulting in tail swelling, has been used to study lymphedema. However, this model may result in vascular comprise and consequent tail necrosis and early tail swelling resolution, limiting its clinical translatability. The chronic murine tail lymphedema model induces sustained lymphedema over 15 weeks and a reliable perfusion to the tail. Enhancements of the traditional murine tail lymphedema model include 1) precise full thickness excision and lymphatic clipping using a surgical microscope, 2) confirmation of post-operative arterial and venous perfusion using high resolution laser speckle, and 3) functional assessment using indocyanine green near infrared laser lymphangiography. We also use tissue nanotransfection technology (TNT) for novel non-viral, transcutaneous, focal delivery of genetic cargo to the mouse tail vasculature.

Lymphedema is extremity swelling caused by lymphatic dysfunction. We describe a chronic murine tail model of lymphedema and the novel use of tissue nanotransfection technology (TNT) for genetic cargo delivery to the tail.

Lymphedema is extremity swelling caused by lymphatic dysfunction. The affected limb enlarges because of accumulation of fluid, adipose, and fibrosis. ...

Monitoring Pulmonary Nodule Progression Using Micro-Computed Tomography and Blood Sampling in a Mouse Model

Micro-computed tomography (micro-CT) is a real-time, intuitive, sensitive, and minimally invasive technique for monitoring changes from pulmonary nodules (PN) to lung cancer (LC). The integration of submandibular vein blood sampling enables rapid, stable, and straightforward detection of imaging and key target alterations during the progression of PN to LC. In this study, we administered a dosage of 100 mg/kg of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice to develop a lung adenocarcinoma model. Disease progression in the experimental animals was then monitored through submandibular vein blood sampling and micro-CT assay. Experimental results showed the presence of nodular foci in the lungs of some animals by the 10th week, with the development of lung adenocarcinoma images becoming evident by the 21st week. In conclusion, micro-CT can effectively observe pathological changes in the lungs of mice and, when combined with submandibular vein blood sampling, can dynamically monitor changes in blood, protein, and targets. This method provides a highly specific, simple, and sensitive approach for drug screening, pharmacokinetic testing, toxicological experiments, and safety studies.

This protocol describes an efficient, simple, and minimally invasive method for studying pulmonary nodules. Submaxillary vein blood collection and micro-CT imaging are used as investigative techniques.

Micro-computed tomography (micro-CT) is a real-time, intuitive, sensitive, and minimally invasive technique for monitoring changes from pulmonary nodules ...

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Podsumowanie

Przeglądaj więcej filmów

Rozdziały w tym wideo

Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models

Non-invasive Optical Imaging of the Lymphatic Vasculature of a Mouse

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes

A Murine Tail Lymphedema Model

Monitoring Pulmonary Nodule Progression Using Micro-Computed Tomography and Blood Sampling in a Mouse Model